Skip to main content
Log in

Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The value of dehydroepiandrosterone sulfate (DHEA-S), a specific marker of adrenal androgen production, in the assessment of clinical states of hypercortisolism and hypocortisolism has been suggested. Since the way to simply test for ACTH reserve in patients (pts) with pituitary tumors after adenomectomy is not standardized, in this study serum DHEA-S concentration was measured in order to establish whether its determination might be a sensitive index of ACTH deficiency. Serum DHEA-S concentration was evaluated in 29 pts with hypothalamic-pituitary tumors (16 females, 13 males, aged 20–70 yr), 14 of whom had GH-secreting ade-nomas, 13 nonfunctioning adenomas, 1 prolactinoma and 1 craniopharyngioma. Serum DHEA-S and Cortisol (F) levels were determined both before and every day for 8 days after pituitary adenomectomy. Before surgery in all pts mean DHEA-S and F basal values were 3.57±0.42 μmol/L and 391.8±29.0 nmol/L, respectively. Eight out of 29 pts showed reduced DHEA-S levels (0.85±0.19 μmol/L), which remained lower than normal in the postsurgical period; on the contrary, F levels were reduced in only 2 and 3 cases before and after surgery, respectively. In 3 other pts DHEA-S levels were normal before surgery and then were low in the postoperative period, while serum Cortisol remained normal in all cases. In most of these patients, the finding of impaired responses to hypothalamic-pituitary-adrenal tests, together with a reduced corticosteroid urinary excretion, confirmed the existence of a secondary hy-poadrenalism and the necessity for an adequate replacement therapy.The remaining 20 pts showed normal DHEA-S and F levels both before and after adenomectomy and did not require replacement therapy. In conclusion: a) in pts operated on by pituitary adenomectomy the determination of serum DHEA-S is useful in order to recognize secondary hypoadrenalism; b) the reduction of DHEA-S levels is accompanied to either altered responsiveness to dynamic tests or low corticosteroids urinary excretion; c) the simultaneous evaluation of DHEA-S and Cortisol levels is suggested in order to early identify pts who will show a secondary hypoadrenalism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cutler G.B., Davis S.E., Johnsonbaugh R.E., Loriaux D.L Dissociation of Cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. J. Clin. Endocrinol. Metab. 49:604,1979.

    Article  PubMed  Google Scholar 

  2. Yamaji T., Ishibashi M., Takaku F., Itabashi A. Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency. J. Clin. Endocrinol. Metab. 65:448,1987.

    Article  CAS  PubMed  Google Scholar 

  3. Yamaji T., Ishibashi M., Sekikara H., Itabashi A., Yanaihara T. Serum dehydroepiandrosterone sulfate in Cushing’ s syndrome. J. Clin. Endocrinol. Metab. 59:11 64,1984.

    Article  CAS  Google Scholar 

  4. Burke C.W. Hormonal testing of pituitary tumours. In: Faglia G., Beck-Peccoz P., Ambrosi B., Travaglini P., Spada A. (Eds.), Pituitary Adenomas: New Trends in Basic and Clinical Research. Intern. Congr.Series 961. Excerpta Medica, Amsterdam, 1991, p. 181.

    Google Scholar 

  5. Donald R. Plasma immuno reactive corticotrophin and Cortisol response to insulin hypoglycemia in normal subjects and in patients with pituitary disease. J. Clin. Endocrinol. Metab. 32: 225, 1971.

    Article  CAS  PubMed  Google Scholar 

  6. Wand G.S., Ney R.L. Disorders of the hypothalamic-pituitary-adrenal axis. Clin. Endocrinol. Metab. 74:33,1985.

    Article  Google Scholar 

  7. Kehlet H., Blichert-Toft M., Lindholm J., Rasmussen P. Short ACTH test in assessing hypothalamic-pituitary- adrenocortical function. Br. Med. J. 7:249,1976.

    Article  Google Scholar 

  8. Borst G.C., Michenfelder H.J., O’Brian J.T. Discordant Cortisol response to exogenous ACTH and insulin induced hypoglycaemia in patients with pituitary disease. N. Engl. J. Med. 306: 1462, 1982.

    Article  CAS  PubMed  Google Scholar 

  9. Cunningham S.K., Moore A., McKenna T.J. Normal Cortisol response to corticotrophin in patients with secondary failure. Arch. Intern. Med. 743:2276,1983.

    Article  Google Scholar 

  10. Hagg E., Asplund K., Lithner F. Value of basal plasma Cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin. Endocrinol. (Oxf.) 26: 221,1986.

    Article  Google Scholar 

  11. Hartzband P.I., Van Herle A., Sorger L, Cope D. Assessment of hypothalamic-pituitary-adrenal axis dysfunction: comparison of ACTH stimulation, insulin- hypoglycemia and metyrapone. J. Endocrinol. Invest. 77:769,1988.

    Google Scholar 

  12. Faglia G., Ambrosi B., Beck -Peccoz P., Travaglini P. Hypothalamic-pituitary-adrenal function in patients with pituitary tumors. Acta Endocrinol. (Copenh.) 73:223, 1973.

    CAS  Google Scholar 

  13. Snyder P.J., Jacobs L.S., Rabello M.M., Sterling F.M., Shore R.N., Utiger R.D., Daughaday W.H. Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases: assessment of thyrotropin and prolactin secretion in 100 patients Ann. Intern. Med. 81: 751,1974.

    Article  CAS  PubMed  Google Scholar 

  14. Tsatsoulis A., Shalet S.M., Harrison J., Ratcliffe W.A., Beardwell C.G., Robinson E.L. Adrenocorticotrophin deficiency undetected by stan dard dynamic tests of the hypothalamic-pituitary- adrenal axis. Clin. Endocrinol. (Oxf.) 28:225,1988.

    Article  CAS  Google Scholar 

  15. Kehlet H., Binder C, Blichert-Toft M. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and prepa ration. Clin. Endocrinol. (Oxf.) 5:37,1976.

    Article  CAS  Google Scholar 

  16. Kehlet H., Nistrup Masden S., Binder C. Cortisol and cortisone acetate in parenteral gluco-corticoid therapy? Acta Med. Scand. 195:421,1974.

    Article  CAS  PubMed  Google Scholar 

  17. Jenkins J.S., Sampson P.A. Conversion of cortisone to Cortisol and prednisone to prednisolone. Br. Med. J. 2: 205, 1967.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hout W.M., Arafah B.M., Salazar R., Selman W. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary? J. Clin. Endocrinol. Metab. 66:1208,1988.

    Article  CAS  PubMed  Google Scholar 

  19. Udelsman R., Norton J.A, Jelenich S.E., Goldstein D.S., Linehan W.M., Loriaux D.L, Chrousos G.P. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J. Clin. Endocrinol. Metab. 64: 986,1987.

    Article  CAS  PubMed  Google Scholar 

  20. Parker L.N., Odell W.D. Control of adrenal androgen secretion. Endocr. Rev. 1:392,1980.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ambrosi, B., Bochicchio, D., Peverelli, S. et al. Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy. J Endocrinol Invest 15, 827–833 (1992). https://doi.org/10.1007/BF03348813

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348813

Key-words

Navigation